Journal of the American Chemical SocietyBiochemistryPeer-reviewed journal article
Chemoenzymatic Synthesis of Glycosphingolipids having an HNK-1 Epitope for Erythrocyte Cell Surface Remodeling
Abstract
Several neuropathies, such as Guillain-Barre syndrome and myelin-associated glycoprotein neuropathy (MAG), are caused by antibodies targeting glycosphingolipids. Several studies have indicated that MAG arises from pathogenic IgM autoantibodies targeting sulfoglucuronyl (HNK-1) containing glycosphingolipids. The exact mechanism by which IgM-neuropathy occurs has not been fully elucidated. Furthermore, no appropriate diagnostic tools are available for MAG using sulfoglucuronyl containing glycosphingolipids. To address these limitations, we describe here a synthetic strategy that makes it possible to prepare sulfoglucuronyl paraglobosides using a neochemo-enzymatic approach. It is based on the enzymatic assembly of N-acetyl-lactosamine (LacNAc) backbones as thioglycosides that were subjected to protecting group manipulations to give glycosyl acceptors for the chemical installation of a sulfated glucuronic acid moiety. A late-stage conversion of the thioglycosides into anomeric fluorides made it possible to enzymatically introduce sphingosine. The resulting compounds were acetylated to provide 3-sulfo-glucuronyl- and glucuronyl-containing glycosphingolipids, respectively. The glycosphingolipids were employed to remodel the surface of erythrocytes to examine complement mediated toxicity by an anti-HNK-1 antibody. It was found that erythrocytes remodeled with exogenous administered HNK-1 containing glycosphingolipid undergo complement dependent lysis when incubated with an IgM anti-CD57 IgM antibody, whereas a compound lacking a sulfate was not able to induce this effect. The approach could be extended to the gangliosides GM1a and GD1a, which have been implicated in Guillain-Barre syndrome. The results highlight that cell surface remodeling will be attractive for diagnosis, disease monitoring and immunological research of diseases associated with pathogenic antibodies targeting glycosphingolipids. TOC graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=76 SRC="FIGDIR/small/642389v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1c5a4e9org.highwire.dtl.DTLVardef@cddba7org.highwire.dtl.DTLVardef@10fc7eborg.highwire.dtl.DTLVardef@10e5678_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 4
- FWCI
- 1.19
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthetic HNK-1 containing glycans provide insight into binding properties of serum antibodies from MAG-neuropathy patients
M. Bunyatov, M. A. Wolfert, … G.-J. Boons·bioRxiv·Jul 25, 2022
- Chemoenzymatically Synthesized O-Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context
Zhiyong Zhang, Ruonan Liang, … Geert‐Jan Boons·Angewandte Chemie International EditionPeer-reviewed·Nov 13, 2025
- Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination
Shannon J. McKie, Alex S. Nicholson, … Janet Elwyn Deane·bioRxiv·Sep 15, 2022
- Plasma Membrane Remodelling in GM2 Gangliosidoses Drives Synaptic Dysfunction
Alex S. Nicholson, David A. Priestman, … Janet Elwyn Deane·bioRxiv·Aug 20, 2024
- Glucosylceramide synthase is required for C6-ceramide nanoliposome-induced organelle stress and cell death
Luke R. Vass, Ella Weber Smith, … Todd E. Fox·bioRxiv·Sep 22, 2026
- Glycan-coated nanoparticles mimicking the ischemic glycocalyx scavenge the complement system conferring protection after experimental ischemic stroke
Gizem Erol, Serena Seminara, … Stefano Fumagalli·bioRxiv·Apr 1, 2026